Literature DB >> 31452197

Will Daratumumab be the next game changer in early thymic precursor-acute lymphoblastic leukaemia?

Sumeet Mirgh1, Rayaz Ahmed1, Narendra Agrawal1, Vishvdeep Khushoo1, Ambar Garg1, Shinto Francis1, Narender Tejwani1, Neha Singh1, Dinesh Bhurani1.   

Abstract

Entities:  

Keywords:  daratumumab; early thymic precursor T-acute lymphoblastic leukaemia; immunotherapy; leukaemia; refractory; stem cell transplantation

Year:  2019        PMID： 31452197     DOI： 10.1111/bjh.16154

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China.

Authors:  Jinyan Xiao; Zihong Cai; Hao Wang; Xuekai Li; Biqi Zhou; Yujie Liu; Ying Wang; Peipei Xu; Li Wang; Depei Wu; Liping Dou; Hongsheng Zhou; Yang Xu
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

Review 2.  Immunotherapy for Refractory Autoimmune Encephalitis.

Authors:  Jiawei Yang; Xueyan Liu
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

Review 3.  Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies.

Authors:  Chun-Fung Sin; Pui-Hei Marcus Man
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

4.  Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.

Authors:  Marco Cerrano; Massimiliano Bonifacio; Matteo Olivi; Antonio Curti; Michele Malagola; Michelina Dargenio; Anna Maria Scattolin; Cristina Papayannidis; Fabio Forghieri; Carmela Gurrieri; Ilaria Tanasi; Patrizia Zappasodi; Roberta La Starza; Nicola Stefano Fracchiolla; Patrizia Chiusolo; Luisa Giaccone; Maria Ilaria Del Principe; Fabio Giglio; Marzia Defina; Claudio Favre; Carmelo Rizzari; Barbara Castella; Giovanni Pizzolo; Felicetto Ferrara; Sabina Chiaretti; Robin Foà
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

Review 5.  Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab.

Authors:  Marilyn T Nedumcheril; Robert A DeSimone; Sabrina E Racine-Brzostek; Ok Kyong Chaekal; Ljiljana V Vasovic
Journal:  J Blood Med       Date:  2021-05-25

Review 6.  Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.

Authors:  Omar Castaneda Puglianini; Nikolaos Papadantonakis
Journal:  Ther Adv Hematol       Date:  2020-07-16

7.  Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases.

Authors:  Ingolf Molle; Irma Petruskevicius; Peter Kamper; Francesco d'Amore
Journal:  Case Rep Hematol       Date:  2022-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.